A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)

Clinical trial NCT03644069 · UNKNOWN

Trial details

NCT number: NCT03644069
Sponsor: ImmusanT, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Celiac Disease Celiac Intestinal Disease Malabsorption Syndromes Gastrointestinal Disease Digestive System Disease Gluten Sensitivity Autoimmune Diseases

Start date: 2018-08-06
Primary completion: 2019-09-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.